| |
SINGAPORE: Catalist-listed Singapore Medical Group (SMG) has warned shareholders that it's likely to report lower profits this year, compared to last year.
This is mainly due to one-off IPO expenses, remunerations for directors which were not incurred in 2008 and pre-operating costs of four newly-opened clinics.
The company also saw lower sales in its opthalmology business.
SMG provides healthcare services across the fields of ophthalmology, aesthetic medicine, sports medicine and oncology. - 938LIVE/vm
|
